The natural product willardiine (8) is an AMPA receptor agonist while 5-iodowillardiine (10) is a selective kainate receptor agonist. In an attempt to produce antagonists of kainate and AMPA receptors analogues of willardiine with substituents at the N3 position of the uracil ring were synthesized. The N3-4-carboxybenzyl substituted analogue (38c) was found to be equipotent at AMPA and GLUK5-containing kainate receptors in the neonatal rat spinal cord. The N3-2-carboxybenzyl substituted analogue (38a) proved to be a potent and selective GLUK5 subunit containing kainate receptor antagonist when tested on native rat and human recombinant AMPA and kainate receptor subtypes. The GLUK5 kainate receptor antagonist activity was found to reside in the S enantiomer (44a) whereas the R enantiomer (44b) was almost inactive. 5-Iodo substitution of the uracil ring of 44a gave 45, which was found to have enhanced potency and selectivity for GLUK5.

Dolman, N., Troop, H., More, J., Alt, A., Knauss, J., Nistico', R.g., et al. (2005). Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors. JOURNAL OF MEDICINAL CHEMISTRY, 48(24), 7867-7881 [10.1021/jm050584l].

Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors

NISTICO', ROBERT GIOVANNI;
2005-01-01

Abstract

The natural product willardiine (8) is an AMPA receptor agonist while 5-iodowillardiine (10) is a selective kainate receptor agonist. In an attempt to produce antagonists of kainate and AMPA receptors analogues of willardiine with substituents at the N3 position of the uracil ring were synthesized. The N3-4-carboxybenzyl substituted analogue (38c) was found to be equipotent at AMPA and GLUK5-containing kainate receptors in the neonatal rat spinal cord. The N3-2-carboxybenzyl substituted analogue (38a) proved to be a potent and selective GLUK5 subunit containing kainate receptor antagonist when tested on native rat and human recombinant AMPA and kainate receptor subtypes. The GLUK5 kainate receptor antagonist activity was found to reside in the S enantiomer (44a) whereas the R enantiomer (44b) was almost inactive. 5-Iodo substitution of the uracil ring of 44a gave 45, which was found to have enhanced potency and selectivity for GLUK5.
2005
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore BIO/14 - FARMACOLOGIA
English
Alanine; Animals; Animals, Newborn; Calcium; Cell Line; Humans; In Vitro Techniques; Long-Term Potentiation; Mossy Fibers, Hippocampal; Nerve Fibers, Unmyelinated; Protein Subunits; Pyrimidinones; Radioligand Assay; Rats; Receptors, AMPA; Receptors, Kainic Acid; Recombinant Proteins; Spinal Cord; Spinal Nerve Roots; Stereoisomerism; Structure-Activity Relationship; Uracil
Dolman, N., Troop, H., More, J., Alt, A., Knauss, J., Nistico', R.g., et al. (2005). Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors. JOURNAL OF MEDICINAL CHEMISTRY, 48(24), 7867-7881 [10.1021/jm050584l].
Dolman, N; Troop, H; More, J; Alt, A; Knauss, J; Nistico', Rg; Jack, S; Morley, R; Bortolotto, Z; Roberts, P; Bleakman, D; Collingridge, G; Jane, D
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
JMedChem'05KARant.pdf

solo utenti autorizzati

Descrizione: Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors
Licenza: Copyright dell'editore
Dimensione 228.51 kB
Formato Adobe PDF
228.51 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/133207
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 51
  • ???jsp.display-item.citation.isi??? ND
social impact